Previous 10 | Next 10 |
2023-11-06 08:12:50 ET More on Mesa Laboratories Mesa Laboratories: Continued Pressure On Equity Re-Rating, Reiterate Hold Mesa Labs buys three GKE entities for €85M to boost revenue Seeking Alpha’s Quant Rating on Mesa Laboratories Historical e...
CGG ADR (CGGYY) is expected to report for quarter end 2023-09-30 ATI Physical Therapy Inc. Class A (ATIP) is expected to report $-4.08 for Q3 2023 Riot Platforms Inc. (RIOT) is expected to report $-0.29 for Q3 2023 Bain Capital Specialty Finance Inc. (BCSF) is expected to report $0.57...
Mesa Laboratories Inc. (MLAB) is expected to report $1.1 for Q2 2024
2023-10-16 03:15:08 ET More on Mesa Laboratories Mesa Laboratories: Continued Pressure On Equity Re-Rating, Reiterate Hold Mesa Laboratories (MLAB) Investor Presentation - Slideshow Seeking Alpha’s Quant Rating on Mesa Laboratories Dividend scorecard f...
Lakewood, Colo., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa”, “we”, “us” or “our”), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today annou...
LAKEWOOD, Colo., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the second quarter of fiscal year 2024 at approximately 8:00 A.M. Eastern time on Monday, November 6, 2023. About Mesa Laboratories, Inc. Mesa ...
LAKEWOOD, Colo., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories Inc (Nasdaq: MLAB; “Mesa” or the “Company”), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced its commitment to calculate a...
2023-08-23 23:09:53 ET Summary Mesa Laboratories, Inc. still faces profitability concerns despite a balanced Q1 FY'24 performance. MLAB's stock has experienced a significant decline, wiping out five years of equity gains in around 12 months or so. MLAB needs to overcome challe...
2023-08-03 08:04:58 ET Mesa Laboratories press release ( NASDAQ: MLAB ): Q1 Non-GAAP EPS of $1.77 beats by $0.27 . Revenue of $50.65M (+0.4% Y/Y) misses by $0.92M . For further details see: Mesa Laboratories Non-GAAP EPS of $1.77 beats by $0.27, revenue o...
LAKEWOOD, Colo., June 21, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the first quarter of fiscal year 2024 at approximately 8:00 A.M. Eastern time on Thursday, August 3, 2023. About Mesa Laboratories, Inc. Mesa is a...
News, Short Squeeze, Breakout and More Instantly...
Mesa Laboratories Inc. Company Name:
MLAB Stock Symbol:
NASDAQ Market:
Mesa Laboratories Inc. Website:
Lakewood, Colo., April 08, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced the closing of its Amended and Restated Credit Agreement (the “Credit Agreement”), which provides up to $200 m...
2024-04-03 07:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
LAKEWOOD, Colo., April 01, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on Friday, May 24, 2024. About Mesa Laboratori...